Roche says it will invest $50bn in the US over the next five years, adding to a rush of similar announcements in the sector.
Key Takeaways
- The $50bn investment over five years is one of the sector's biggest
The $50bn commitment is one of biggest announced in recent months and includes the creation of a new research R&D site in Massachusetts and a new manufacturing site for Roche’s future obesity drugs, even though these are currently
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?